Hi, new to the forum but long time reader
A couple months ago i run into a study about a safe topical antiandrogen being developed by Novan Therapeutics:
The hamster flank organ test results were very similar to RU58831: 55% of growth inhibition. Pretty exciting stuff, I think.
They plan to finish phase II for acne in early 2014 testing the 3% concentration, which hopefully will work for MPB too, as it was the one exhibiting more powerful antiandrogenic activity during the study.
Really sucks the company prioritize the acne version. Hate that… Are these pharma startups afraid of bringing something effective for hair loss sufferers? Always the same pattern…
Anyway, plan to contact Novan soon and ask about the benefits of the acne formulation for hairloss.
On the bright side, gel vehicle may not be an issue since its currently beeing tested for MPB by taiwanese investigators:
We should pay attention to those results when released.
Saludos
A couple months ago i run into a study about a safe topical antiandrogen being developed by Novan Therapeutics:
The hamster flank organ test results were very similar to RU58831: 55% of growth inhibition. Pretty exciting stuff, I think.
They plan to finish phase II for acne in early 2014 testing the 3% concentration, which hopefully will work for MPB too, as it was the one exhibiting more powerful antiandrogenic activity during the study.
Really sucks the company prioritize the acne version. Hate that… Are these pharma startups afraid of bringing something effective for hair loss sufferers? Always the same pattern…
Anyway, plan to contact Novan soon and ask about the benefits of the acne formulation for hairloss.
On the bright side, gel vehicle may not be an issue since its currently beeing tested for MPB by taiwanese investigators:
We should pay attention to those results when released.
Saludos
Comment